MACLEODS PHARMACEUTICALS LTD

Year of Establishment: 1989

Total Assets(USD):

Total Number of Staff: more than 1000

Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service

Other Competitive Advantages: Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. This quest, for healing the world, drives our performance and helps us move towards our Vision.Flagship company for Anti TB products globally, also number 1 pharmaceutical company in India for generics Our expertise We are present across varied therapies such as antituberculosis, antimalarials, antiretrovirals, antibacterials, antidiabetics, antihypertensives and antiasthmatics. We are also known for the number of WHO pre-qualified medicines, used in the treatment of HIV/AIDS, Malaria, Tuberculosis (TB) and opportunistic infections. What we do We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers.

Patents and Copyrights: